Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 63629-8469

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 63629-8469). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-01 (Figure 01)

A line graph titled 'Effect of Atorvastatin Calcium 10 mg/day on Cumulative Incidence of Non-Fatal Myocardial Infarction or Coronary Heart Disease Death (in ASCOT-LLA)'. It plots cumulative incidence percentage on the vertical axis against time in years on the horizontal axis, comparing Atorvastatin and Placebo groups. The graph shows lower cumulative incidence for Atorvastatin compared to Placebo over approximately 3.5 years.*

FDA Label Image

Figure-02 (Figure 02)

A line graph titled 'Effect of Atorvastatin Calcium 10 mg/day on Time to Occurrence of Major Cardiovascular Event.' The y-axis shows cumulative hazard percentage, and the x-axis shows time in years (up to 5 years). Two lines compare placebo (dashed) and Atorvastatin (solid), with Atorvastatin showing a lower cumulative hazard over time. Statistical data HR=0.63 (0.48-0.83), p=0.001 is included.*

FDA Label Image

Figure-03 (Figure 03)

A line graph showing the effect of Atorvastatin Calcium 80 mg/day versus 10 mg/day on the time to occurrence of major cardiovascular events. The x-axis represents time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows the percentage of subjects experiencing the event (0 to 0.2). Two lines compare 10 mg (dashed) and 80 mg (solid) doses, with the 80 mg line generally below the 10 mg line, indicating fewer events over time at the higher dose. The graph includes a hazard ratio (HR=0.78) with confidence intervals and a p-value (p=0.0002).*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of atorvastatin calcium showing the molecular arrangement including phenyl groups, hydroxyl groups, and the calcium ion complex.*

FDA Label Image

Label (Lbl636298469)

Label for Atorvastatin Calcium Tablets, USP 10 mg, film-coated oral tablets. The label shows the NDC 63629-8469-1, specifies a package of 90 tablets, and is labeled by Bryant Ranch Prepack. The label includes manufacturer details (Sciegen Pharmaceuticals, Hauppauge, NY) and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.